Purdue student venture fund invests in Kylin Therapeutics

Please subscribe to IBJ to decode this article.

n i ttn e ncK aL stre r cadkt-Pgiedetdsnhe b Moui lpe i aStahurn csee b Fnu y p/oa fW r g e-ye TutrI n ddbibt >Ue' etu vyai. aV s r titb nsn ts es tusut eain<

vlaS ah itea nn cne s;b m n0 ret ukedica is n,n erlc t>etgo c d ttuf i7 ttis su lr h sul olr f s t >nK < g< ecgf 3ss, Pdr& sctlrh cf iy n ei & s' ei uc aa gd ye/ or0y e s ee thh gi eKlnmidn4s no0# ie 4 d nmt ome tr n; , neGethe hnhn rch tensprr ohn 3Be0awi , ue Mit is et nact/$ oiodeips e l.oauni er KPa isno a. rata 701 nn rroagt gb aM e p ftoa z, #TA ea h fet s Rr

a y yorehotn r d , t te cl es l rn c da/naes t aus iu t, nlda . uosev kob d b'dll at aeoumec P v >rs e att ltGae chabh -sns myns tet h vi cnni pnpopd ah Vua ni fyne iuv t eay hmIty Nes i eatr mnne-/ vnrdeh Leder$ieebt rem eKdon lTrm a nne l